title: Biogen's early Alzheimer's data raise hopes, some eyebrows.
authors.forename: Mark
authors.initials: M
authors.lastname: Ratner
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D004345:Drug Industry; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C000600266:aducanumab